Leveraging our clinical study experience and understanding of pharmacological mechanisms, Aeirtec is able to provide invaluable assistance to our clients in interpreting the data we generate for them. This collaborative relationship extends to supporting our clients in writing publications related to clinical studies, incorporating the evidence our data provides.

At Aeirtec, our dedicated team has consolidated and enhanced their expertise in biomarker activity through direct experience of the challenges faced in delivering clinical studies. We have three decades of first-hand experience as a clinical site management organization involved in design and conduct of clinical protocols.

Recognizing the complex nature of unmet need therapeutic areas, Aeirtec understands the critical importance of integrating multiple clinical biomarker data through multivariate statistics.

This integration proved to be powerful in providing surrogate efficacy endpoints and demonstrating therapeutic mechanisms of action in clinical studies where univariate statistics of individual biomarkers could not.

Immobilised-Bead Immunomultiplex Assay Patent